AMERICAN HEART ASSOCIATION DALLAS, March 27, 2019 — Despite national guidelines indicating that statins can lower risk of heart attack and stroke, many patients who could benefit do not take them. More than half of eligible patients say they were never offered the cholesterol-lowering drugs; the experience of side effects or fear of side effects were reasons for stopping or refusing statins, according to new research in Journal of the American Heart Association, the Open...
Tag: <span>cholesterol</span>
Post
New cholesterol-lowering drug could help patients unable to take statins
A new class of oral cholesterol-lowering drug could help patients unable to take statins due to side effects. The findings come from the largest study to date to test the effectiveness and safety of bempedoic acid, an oral medication—yet to be approved in Europe—which inhibits the body’s ability to create the building blocks of cholesterol. The research, published today in the New England Journal of Medicine, reports on findings from...
Post
Cholesterol-lowering drugs guard against brain haemorrhages
The drugs statins, which are used to prevent cardiovascular diseases, also guard against brain haemorrhages; this is the conclusion from a new Danish study, the most extensive ever, which thus also rebuffs suspicions of the opposite being true AARHUS UNIVERSITY The drugs statins, which are used to prevent cardiovascular diseases, also guard against brain haemorrhages. This is the conclusion of most extensive study ever carried out, which...
Post
Montmorency tart cherry juice helped lower blood pressure and LDL ‘bad’ cholesterol
Research provides new reasons to eat (and drink) red for American Heart Month WEBER SHANDWICK CHICAGO LANSING, Mich. February 11, 2019 – Montmorency tart cherry juice helped lower systolic blood pressure and LDL or “bad” cholesterol in older adults by reducing certain biomarkers of inflammation and oxidative stress in older adults, according to a new...
Post
Using genetics of human fat cells to predict response to anti-diabetes drugs
Predicting Response to Anti-Diabetes Drugs Credit: Mitchell Lazar lab, Metabolism in the Perelman School of Medicine at the University of Pennsylvania Drugs called thiazolidinediones (TZDs) reverse insulin resistance in patients with type 2 diabetes by targeting the activity of a receptor protein. However, an array of side effects, including weight gain, edema, and high cholesterol,...
Post
Egg metabolites in blood related to lower risk of type 2 diabetes
Consumption of one egg every day seems to associate with a blood metabolite profile that is related to a lower risk of type 2 diabetes, a new study conducted in the University of Eastern Finland shows. The findings were published in Molecular Nutrition and Food Research. Eggs remain one of the most controversial food items. High intake of eggs has traditionally been discouraged, mainly due to their...
Post
Cholesterol-lowering drugs reduce brown adipose tissue
A certain proportion of the adult population has not only white adipose (or fatty) tissue, but also the brown kind. This brown adipose tissue helps to convert sugar and fat into heat. People with brown adipose tissue are better at regulating their body temperature in the winter, and are less likely to suffer from excess...
Post
3 things to know about cholesterol
With the release of new guidelines for treating and managing cholesterol, there may be questions not only about the changes in the update but about cholesterol itself. Most people know that high cholesterol is bad. But there’s a bigger picture involved when determining what’s considered too high. Put another way, the same number could be...
Post
A new drug lowers cholesterol. Can it spoil a multibillion-dollar market?
A small biotech company has a shot at shaking up a market roosted by giants, moving toward approval with a pill it believes can lower bad cholesterol at a discount to other medicines. On Sunday, Esperion Therapeutics said a combination of its once-a-day treatment and a maximum dose of statin lowered LDL cholesterol 18 percent...
Post
How does manganese enter the brain? Research offers clues to neurological disorder
New information from the University at Buffalo on how manganese, an essential nutrient, gets into the brain, is helping shed light on a neurological disorder usually associated with industrial overexposure to the metal. In June, Brittany Steimle, a doctoral candidate in biochemistry at UB, received the award for outstanding poster for her presentation on how...